Android Apple

EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations

By Yahoo! Finance   |   3 weeks ago
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations

Adial Pharmaceuticals announced the issuance of a new patent expanding its intellectual property coverage for treating alcohol use disorder with AD04. The patent covers genotype combinations crucial for the company's precision medicine approach and supports its pipeline expansion.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.